PHARMACOKINETICS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER LONG-TERM THERAPY IN DIALYSIS PATIENTS

被引：0
|
作者：
GLADZIWA, U
BAUMER, K
KLOTZ, U
DAKSHINAMURTY, KV
MANN, H
SIEBERTH, HG
机构：
[1] DEPT INTERNAL MED 2,AACHEN,GERMANY
[2] CLIN PHARMACOL,STUTTGART,GERMANY
来源：
KIDNEY INTERNATIONAL | 1992年 / 41卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：482 / 483
页数：2
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF EPOETIN (RECOMBINANT-HUMAN-ERYTHROPOIETIN) AFTER LONG-TERM THERAPY IN PATIENTS UNDERGOING HEMODIALYSIS AND HEMOFILTRATION
    GLADZIWA, U
    KLOTZ, U
    BAUMER, K
    ZOLLINGER, R
    MANN, H
    SIEBERTH, HG
    [J]. CLINICAL PHARMACOKINETICS, 1993, 25 (02) : 145 - 153
  • [2] RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN PEDIATRIC-PATIENTS RECEIVING LONG-TERM PERITONEAL-DIALYSIS
    WARADY, BA
    SABATH, RJ
    SMITH, CA
    ALON, U
    HELLERSTEIN, S
    [J]. PEDIATRIC NEPHROLOGY, 1991, 5 (06) : 718 - 723
  • [3] PHARMACOKINETICS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN DIALYSIS PATIENTS AFTER SINGLE AND MULTIPLE SUBCUTANEOUS ADMINISTRATIONS
    KAMPF, D
    ECKARDT, KU
    FISCHER, HC
    SCHMALISCH, C
    EHMER, B
    SCHOSTAK, M
    [J]. NEPHRON, 1992, 61 (04) : 393 - 398
  • [4] HEMODIALYSIS EFFICIENCY AFTER LONG-TERM TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    CASATI, S
    CAMPISE, M
    CREPALDI, M
    LOBO, J
    GRAZIANI, G
    PONTICELLI, C
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (08) : 718 - 720
  • [5] PHARMACOKINETICS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    SINYUKHIN, VN
    STETSYUK, YA
    LOVCHINSKY, YV
    LEBEDEV, SV
    YARMOLINSKY, IS
    LYAKHOV, VV
    [J]. TERAPEVTICHESKII ARKHIV, 1994, 66 (08): : 60 - 62
  • [6] PHARMACOKINETICS AND HEMATOLOGIC RESPONSE TO SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN CHILDREN UNDERGOING LONG-TERM PERITONEAL-DIALYSIS - A MULTICENTER STUDY
    MONTINI, G
    ZACCHELLO, G
    PERFUMO, F
    EDEFONTI, A
    BASSI, S
    CANTALUPPI, A
    SARCHI, C
    CAZZIN, M
    FERRARI, V
    BOCCAZZI, A
    CARINGELLA, A
    CATTARELLI, D
    COPPO, R
    LONGO, L
    SORINO, P
    VERRINA, E
    GUSMANO, R
    [J]. JOURNAL OF PEDIATRICS, 1993, 122 (02): : 297 - 302
  • [7] EFFECT OF RACE ON ACCESS TO RECOMBINANT-HUMAN-ERYTHROPOIETIN IN LONG-TERM HEMODIALYSIS-PATIENTS
    PETRONIS, KR
    CARROLL, CE
    HELD, PJ
    PORT, FK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (22): : 1760 - 1763
  • [8] PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    BROCKMOLLER, J
    KOCHLING, J
    SCIGALLA, P
    WEBER, W
    ROOTS, I
    NEUMAYER, HH
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (06) : 2391 - 2392
  • [9] THE LONG-TERM EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON THE CARDIOVASCULAR-SYSTEM
    ESCHBACH, JW
    AQUILING, T
    HALEY, NR
    FAN, MH
    BLAGG, CR
    [J]. CLINICAL NEPHROLOGY, 1992, 38 : S98 - S103
  • [10] HEME METABOLISM IN HEMODIALYZED PATIENTS AFTER RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY
    ALONSO, JLM
    SOLIS, C
    BORREGO, F
    HERRERO, E
    FERNANDEZ, MJ
    SANCHEZ, MT
    ARA, JM
    [J]. KIDNEY INTERNATIONAL, 1992, 42 (01) : 215 - 215
12345